Noticias de FOLD_US

Noticias del mercado

Últimas noticias sobre FOLD_US — 55 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: FOLD_US ✕ 55 resultados
23/04/2026 FOLD_US — Investing.com
BioMarin receives French clearance for Amicus merger, closing expected soon
23/04/2026 FOLD_US — TradingView
Amicus receives French FDI clearance, merger with BioMarin set to close April 27, 2026
23/04/2026 FOLD_US — Stock Titan
French approval clears way for Amicus (NASDAQ: FOLD) merger with BioMarin
23/04/2026 FOLD_US — MarketBeat
Amicus Therapeutics (NASDAQ:FOLD) Sets New 12-Month High - Time to Buy?
23/04/2026 FOLD_US — Investing.com
Amicus Therapeutics stock hits 52-week high at $14.48
23/04/2026 FOLD_US — laocai.gov.vn
FOLD (Amicus Therapeutics Inc.) posts steep Q4 2025 EPS miss, shares edge up slightly in daily trading. - Trending Stock Ideas
22/04/2026 FOLD_US — tayninh.gov.vn
FOLD (Amicus Therapeutics Inc.) posts steep Q4 2025 EPS miss, shares edge up slightly in daily trading. - Trending Social Stocks
21/04/2026 FOLD_US — Stock Traders Daily
How Amicus Therapeutics Inc. (FOLD) Affects Rotational Strategy Timing
20/04/2026 FOLD_US — laocai.gov.vn
Why is Amicus Therapeutics (FOLD) stock moving (Unchanged) 2026-04-20 - Public Sentiment
20/04/2026 FOLD_US — vinhcong.tayninh.gov.vn ES ← EN
¿Por qué se mueven las acciones de Amicus Therapeutics (FOLD)? (Sin cambios) 2026-04-20 - Sentimiento público
20/04/2026 FOLD_US — tayninh.gov.vn
Why is Amicus Therapeutics (FOLD) stock moving (Unchanged) 2026-04-20 - Social Trading Insights
20/04/2026 FOLD_US — syt.laocai.gov.vn
Why is Amicus Therapeutics (FOLD) stock moving (Unchanged) 2026-04-20 - Public Sentiment
18/04/2026 FOLD_US — MarketBeat
Massachusetts Financial Services Co. MA Has $1.79 Million Position in Amicus Therapeutics, Inc. $FOLD
18/04/2026 FOLD_US — MarketBeat
Amicus Therapeutics (NASDAQ:FOLD) Share Price Crosses Above 200 Day Moving Average - Here's What Happened
18/04/2026 FOLD_US — Markets Mojo
Amicus Therapeutics Experiences Revision in Stock Evaluation Amid Mixed Performance Indicators
15/04/2026 FOLD_US — Markets Mojo
Amicus Therapeutics, Inc. Experiences Revision in Stock Evaluation Amid Strong Market Performance
10/04/2026 FOLD_US — MarketBeat
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Given Consensus Rating of "Hold" by Brokerages
09/04/2026 FOLD_US — Markets Mojo
Amicus Therapeutics Hits New 52-Week High of $14.48
08/04/2026 FOLD_US — Markets Mojo
Amicus Therapeutics Hits New 52-Week High of $14.47
07/04/2026 FOLD_US — Intellectia AI ES ← EN
FOLD Financials: desglose de ingresos, márgenes y comparación con la competencia

Página 1 de 3

keyboard_arrow_up